{"type":"PR","pr":{"number":27,"head":"b85e6da91237c95c8e4fcbee44ec7d63ada0a81a"},"user":"silvia.vernotico","status":"pending_publish","branch":"cms/2018-09-09-hot-this-week-in-farmaceutica-younger-n-66","collection":"hotthisweek","title":"HOT THIS WEEK IN FARMACEUTICA YOUNGER N.66","description":"Sanofi ha ottenuto dalla Commissione europea l’ok per l’autorizzazione all’immissione in commercio di caplacizumab (ALX-0081), prima terapia specifica per il trattamento della aTTP (porpora trombotica trombocitopenica acquisita).","objects":{"entry":{"path":"site/content/hotthisweek/2018-09-09-hot-this-week-in-farmaceutica-younger-n-66.md","sha":"82f1e4fbcf12b7c5f470fdb912c91571d05da58a"},"files":[{"path":"/site/static/img/image1.jpeg","sha":"e706df0480cd66bbc924e1de6ba3e2c8dd3ffe53"}]},"timeStamp":"2018-09-09T08:27:34.452Z"}